Predictive Performance of the ‘Minto’ Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass-Reference-Cited by-同舟云学术

Predictive Performance of the ‘Minto’ Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass

Published:2010-02 Issue:2 Volume:49 Page:131-139
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

La Colla Luca,Albertin Andrea,La Colla Giorgio,Porta Andrea,Aldegheri Giorgio,Di Candia Domenico,Gigli Fausto

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

1. Obesity in anaesthesia and intensive care

2. Functional and Structural Changes in the Kidney in the Early Stages of Obesity

3. Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium: An Age-Stratified Study;Pain and Therapy;2023-03-08

2. Using Lean tools to improve the efficiency of awake fibreoptic intubation setup;BMJ Open Quality;2021-12

3. Obesity and anesthetic pharmacology: simulation of target-controlled infusion models of propofol and remifentanil;Korean Journal of Anesthesiology;2021-12-01

4. Perioperative management of patients with concomitant morbid obesity. Guidelines of the All-Russian public organization "Federation of Anesthesiologists and Reanimatologists";Annals of critical care;2021

5. Improved haemodynamic stability and cerebral tissue oxygenation after induction of anaesthesia with sufentanil compared to remifentanil: a randomised controlled trial;BMC Anesthesiology;2020-10-07